Microbial communities form rich extracellular metabolomes that foster metabolic interactions and promote drug tolerance
2022 · Nature Microbiology · 121 citations
https://doi.org/10.1038/s41564-022-01072-5
M
Mary Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
6.2K
Citations
36
h-index
62
i10-index
Mary Wu is an academic researcher from The Francis Crick Institute. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 36, co-authored 106 publications.
ORCID: 0000-0002-2074-6171Papers by this author
worksSARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
2022 · Science Translational Medicine · 105 citations
https://doi.org/10.1126/scitranslmed.abn3715
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
2021 · Nature Cancer · 89 citations
https://doi.org/10.1038/s43018-021-00275-9
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis
2020 · Nature Communications · 44 citations
https://doi.org/10.1038/s41467-020-15615-z
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
2024 · The Lancet Rheumatology · 26 citations
https://doi.org/10.1016/s2665-9913(24)00065-1
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
2024 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-024-55110-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat